Carbapenem-Resistant Pseudomonas aeruginosa at US Emerging Infections Program Sites, 2015

Pseudomonas aeruginosa is intrinsically resistant to many antimicrobial drugs, making carbapenems crucial in clinical management. During July–October 2015 in the United States, we piloted laboratory-based surveillance for carbapenem-resistant P. aeruginosa (CRPA) at sentinel facilities in Georgia, N...

Descripción completa

Detalles Bibliográficos
Autores principales: Walters, Maroya Spalding, Grass, Julian E., Bulens, Sandra N., Hancock, Emily B., Phipps, Erin C., Muleta, Daniel, Mounsey, Jackie, Kainer, Marion A., Concannon, Cathleen, Dumyati, Ghinwa, Bower, Chris, Jacob, Jesse, Cassidy, P. Maureen, Beldavs, Zintars, Culbreath, Karissa, Phillips, Walter E., Hardy, Dwight J., Vargas, Roberto L., Oethinger, Margret, Ansari, Uzma, Stanton, Richard, Albrecht, Valerie, Halpin, Alison Laufer, Karlsson, Maria, Rasheed, J. Kamile, Kallen, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2019
Materias:
Synopsis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590762/
https://www.ncbi.nlm.nih.gov/pubmed/31211681
http://dx.doi.org/10.3201/eid2507.181200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590762/
https://www.ncbi.nlm.nih.gov/pubmed/31211681
http://dx.doi.org/10.3201/eid2507.181200

Ejemplares similares